Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
FDA approval, if granted, would likely occur in late 2026 or early 2027 based on typical review timelines
Those with specific contraindications: Personal or family history of medullary thyroid carcinoma or MEN2 syndrome, history of pancreatitis
After food intake, the active form of GLP-1 is released into the circulation and activates specific G-protein coupled receptors
Oral Semaglutide (SNAC) is a prescription GLP-1 medication designed to support healthy weight loss, appetite control, and blood sugar regulationall in a convenient once-daily capsule
Key distinction: Patient-specific compounding under 503A requires a valid prescription from a licensed provider for a specific patient based on a clinical evaluation
US$ 23.21
US$ 28.70
US$ 26.08
US$ 28.49
US$ 23.20
